Notice of Results

RNS Number : 8764O

Futura Medical PLC

16 March 2009

 



For immediate release

16 March 2009

Futura Medical plc

('Futura' or 'the Company')

Notification of Preliminary Results

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that it will issue its preliminary results for the year ended 31 December 2008 on 13 May 2009. 

The results are being announced in May as the Company has only just entered its close period ahead of the results following the Executive Directors' purchase of shares in the Company in the recent fundraising announced on 6 March 2009.

A meeting for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.

James Barder, Futura's Chief Executive, commented: 'We continue to make solid progress across our portfolio of product opportunities and look forward to updating the market at the time of the results.'

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.co.uk
Canaccord Adams
Ryan Gaffney / Adria Da Breo Richards	Tel: [phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.co.uk

 

END

 

 

NORBELLFKXBXBBK